PAH Therapies Don’t Increase Risk of Respiratory Infections, Chinese Study Shows
A retrospective study showed that pulmonary arterial hypertension (PAH)-specific drug therapies do not raise the risk of respiratory tract infections (RTIs). The Chinese study, “Incidence and risk of respiratory tract infection associated with specific drug therapy in pulmonary arterial hypertension: a systematic review” appeared in the journal…